Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure

Critical Care

Volumn 13, Issue 1, 2009, Pages

  Parés, Albert ^a   Deulofeu, Ramón ^a   Cisneros, Laura ^a   Escorsell, Angels ^a   Salmerón, Joan ^a   Caballería, Joan ^a   Mas, Antoni ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; AROMATIC AMINO ACID; BILIRUBIN; BRANCHED CHAIN AMINO ACID; PHENOL DERIVATIVE; ALBUMINOID;

ADULT; ALBUMIN DIALYSIS; ALCOHOL LIVER DISEASE; AMINO ACID BLOOD LEVEL; AMMONIA BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER FAILURE; LIVER FUNCTION TEST; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; BLOOD; COMPARATIVE STUDY; DIALYSIS; METABOLISM; METHODOLOGY; MIDDLE AGED;

ALBUMINS; AMINO ACIDS, AROMATIC; DIALYSIS; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS, ALCOHOLIC; HUMANS; LIVER FAILURE; MALE; MIDDLE AGED; PHENOLS;

EID: 60749102384     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc7697     Document Type: Article

References (37)

1. Blei AT Hepatic encephalopathy Clinical Hepatology Oxford: Oxford University Press Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodés J 2 1999:764-783
2. Pugh RNH Murray-Lyon IM Dawson JL Pietroni MC Williams R Transection of the oesophagus for bleeding oesophageal varices Br J Surg 1973, 60:646-649 10.1002/bjs.1800600817 4541913
3. Bustamante J Rimola A Ventura JP Navasa M Cirera I Reggiardo V Rodés J Prognostic significance of hepatic encephalopathy in patients with cirrhosis J Hepatol 1999, 30:890-895 10.1016/ S0168-8278(99)80144-5 10365817
4. Butterworth RF The neurobiology of hepatic encephalopathy Semin Liver Dis 1996, 16:235-244 10.1055/s-2007-1007236 8989809
5. Norenberg MD Astrocytic-ammonia interactions in hepatic encephalopathy Semin Liver Dis 1996, 16:245-253 10.1055/s-2007-1007237 8989810
6. Fischer JE Baldessarini RJ False neurotransmitters and hepatic failure Lancet 1971, 2:75-80 10.1016/S0140-6736(71)92048-4 4103986
7. Fischer JE Yoshimura N Aguirre A James JH Cummings MG Abel RM Deindoerfer F Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions Am J Surg 1974, 127:40-47 10.1016/0002-9610(74)90009-9 4808685
8. Fischer JE Funovics JM Aguirre A James JH Keane JM Wesdorp RI Yoshimura N Westman T The role of plasma amino acids in hepatic encephalopathy Surgery 1975, 78:276-290 807982
9. Rosen HM Yoshimura N Hodgman JM Fischer JE Plasma amino acid patterns in hepatic encephalopathy of differing etiology Gastroenterology 1977, 72:483-487 832796
10. Stange J Mitzner S A carrier-mediated transport of toxins in hybrid membrane. Safety barrier between a patient's blood and a bioartificial liver Int J Artif Organs 1996, 19:677-691 8970836
11. Mitzner SR Stange J Klammt S Risler T Erley CM Bader BD Berger ED Lauchart W Peszynski P Freytag J Hickstein H Loock J Löhr JM Liebe S Emmrich J Korten G Schmidt R Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial Liver Transpl 2000, 6:277-286 10.1053/lv.2000.6355 10827226
12. Schmidt LE Sørensen VR Svendsen LB Hansen BA Larsen FS Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure Liver Transpl 2001, 7:1034-1039 10.1053/jlts.2001.29108 11753905
13. Jalan R Sen S Steiner C Kapoor D Alisa A Williams R Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis J Hepatol 2003, 38:24-31 10.1016/ S0168-8278(02)00334-3 12480556
14. Hassanein T Tofteng F Brown RS Jr McGuire B Lynch P Mehta R Larsen FS Gornbein J Stange J Blei AT Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis Hepatology 2007, 46:1853-1862 10.1002/hep.21930 17975845
15. Parés A Cisneros L Salmerón JM Caballería L Mas A Torras A Rodés J Extracorporeal albumin dialysis: A procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis Am J Gastroenterol 2004, 99:1105-1110 10.1111/ j.1572-0241.2004.30204.x 15180733
16. Conn HO Leevy CM Vlahcevic ZR Rodgers JB Maddrey WC Seeff L Levy LL Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial Gastroenterology 1977, 72:573-583 14049
17. Conn HO Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy Am J Dig Dis 1977, 22:541-552 10.1007/BF01072510 868833
18. Amodio P Quero JC del Piccolo F Gatta A Schalm SW Diagnostic tools for the detection of subclinical hepatic encephalopathy: Comparison of standard and computerized psychometric tests Metab Brain Dis 1996, 11:315-327 10.1007/BF02029493 8979251
19. Stange J Ramlow W Mitzner S Schmidt R Klinkmann H Dialysis against a recycled albumin solution enables the removal of albumin bound toxins Artif Organs 1993, 17:809-813 8240075
20. Parés A Bosch J Bruguera M Rodés J Características clínicas y criterios pronósticos en la hepatitis aguda alcohólica Gastroenterol Hepatol 1978, 1:118-122
21. McCullough AJ O'Connor B Alcoholic liver disease: Proposed recommendations for the American College of Gastroenterology Am J Gastroenterol 1998, 93:2022-2036 10.1111/j.1572-0241.1998.00587.x 9820369
22. Cabré E Rodriguez-Iglesias P Caballería J Quer JC Sánchez-Lombraña JL Parés A Papo M Planas R Gassull MA Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trial Hepatology 2000, 32:36-42 10.1053/jhep.2000.8627 10869286
23. Mathurin P Mendenhall CL Carithers RL Jr Ramond MJ Maddrey WC Garstide P Rueff B Naveau S Chaput JC Poynard T Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): Individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe alcoholic hepatitis J Hepatol 2002, 36:480-487 10.1016/S0168-8278(01)00289-6 11943418
24. Blei AT Córdoba J Hepatic encephalopathy Am J Gastroenterol 2001, 96:1968-1976 10.1111/j.1572-0241.2001.03964.x 11467622
25. Wahren J Denis J Desurmont P Eriksson LS Escoffier JM Gauthier AP Hagenfeldt L Michel H Opolon P Paris JC Veyrac M Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study Hepatology 1983, 3:475-450 6345330
26. Michel H Bories O Aubin JP Pomier-Layrargues G Bauret P Bellet-Herman H Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study in 70 patients Liver 1985, 5:282-289 4079669
27. Egberts EH Schomerus H Hamster W Jürgens P Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study Gastroenterology 1985, 88:887-895 3882509
28. Vilstrup H Gluud C Hardt F Kristensen M Køhler O Melgaard B Dejgaard A Hansen BA Krintel JJ Schütten HJ Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis J Hepatol 1990, 10:291-296 10.1016/0168-8278(90)90135-E 2195106
29. Marchesini G Dioguardi FS Bianchi GP Zoli M Bellati G Roffi L Martines D Abbiati R Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group. J Hepatol 1990, 11:91-101 10.1016/0168-8278(90)90278-Y
30. Plauth M Egberts EH Hamster W Török M Müller PH Brand O Fürst P Dölle W Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study J Hepatol 1993, 17:308-314 10.1016/ S0168-8278(05)80210-7 8445234
31. Schmidt LE Tofteng F Strauss GI Larsen FS Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy Scand J Gastroenterol 2004, 39:974-980 10.1080/ 00365520410003227 15513337
32. Heemann U Treichel U Loock J Philipp T Gerken G Malago M Klammt S Loehr M Liebe S Mitzner S Schmidt R Stange J Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study Hepatology 2002, 36:949-958 12297843
33. Butterworth RF Role of circulating neurotoxins in the pathogenesis of hepatic encephalopathy: Potential for improvement following removal by liver assist devices Liver Int 2003, 23(suppl 3):5-9 12950954
34. Mitzner SR Stange J Klammt S Peszynski P Schmidt R Nöldge-Schomburg G Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure J Am Soc Nephrol 2001, 12(Suppl 17):S75-S82 11316845
35. Shawcross D Jalan R Dispelling myths in the treatment of hepatic encephalopathy Lancet 2005, 365:431-433 15680459
36. Larsen FS Gottstein J Blei AT Cerebral hyperemia and nitric oxide synthase in rats with ammonia-induced brain edema J Hepatol 2001, 34:548-554 10.1016/S0168-8278(00)00069-6 11394654
37. Shawcross D Davies N Willians R Jalan R Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammoniemia in cirrhosis J Hepatol 2004, 40:247-254 10.1016/j.jhep.2003.10.016 14739095